PubMed ID:
25039930
Public Release Type:
Journal
Publication Year: 2015
Affiliation: Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI, 48109-0362, USA.
DOI:
https://doi.org/10.1111/liv.12632
Authors:
Fontana RJ,
Ellerbe C,
Durkalski VE,
Rangnekar A,
Reddy RK,
Stravitz T,
McGuire B,
Davern T,
Reuben A,
Liou I,
Fix O,
Ganger DR,
Chung RT,
Munoz S,
Reddy R,
Stravitz R,
Rossaro L,
Satyanarayana R,
Hassanein T,
Samuel G,
Lalani E,
Pezzia C,
Sanders C,
Attar N,
Reisch JS,
Hynan LS,
Smith JP,
Webster JW,
Murray M,
Durkalski V,
Zhao W,
Dillon C,
Schilsky M,
Goddard T,
Han S,
Hynan LS,
Sanders C,
Lee WM,
US Acute Liver Failure Study Group,
Lee WM,
Ostapowicz GA,
Schiødt FV,
Polson J,
Larson AM,
Liou I,
Davern T,
Fix O,
Schilsky M,
McCashland T,
Hay JE,
Murray N,
Shaikh A,
Blei A,
Ganger D,
Zaman A,
Han SH,
Fontana R,
McGuire B,
Chung RT,
Smith A,
Brown R,
Crippin J,
Harrison E,
Reuben A
Studies:
Acute Liver Failure Study Group: Adult Acute Liver Failure Study
The long-term clinical outcomes in initial survivors with acute liver failure (ALF) are not well known. The aim of this study was to provide an overview of the 2-year clinical outcomes among initial survivors and liver transplant (LT) recipients that were alive 3 weeks after enrolment in the Acute Liver Failure Study Group (ALFSG).